Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Open accessThe DOI matches its Crossref record; 235 of the 239 references it cites were found in a registry or an index.
Abstract
These guidelines were formulated to assist physicians and other health care professionals with various aspects of the administration of outpatient parenteral antimicrobial therapy (OPAT). Although there are many reassuring retrospective studies on the efficacy and safety of OPAT, few prospective studies have been conducted to compare the risks and outcomes for patients who receive treatment as outpatients rather than as inpatients. Because truly evidence-based studies are lacking, the present guidelines are formulated from the collective experience of the committee members and advisors from related organizations. Important aspects of OPAT are described in the text and tables and include the following: The literature supports the effectiveness of OPAT for a wide variety of infections (table 1 and the Appendix). Infections treated with outpatient parenteral antimicrobial therapy (OPAT) and the antibiotics used in 4 studies or sites. A thorough assessment of the patient's general medical condition, the infectious process, and the home situation is necessary before starting therapy (table 2) Specific considerations in evaluating patients for outpatient parenteral antimicrobial therapy (OPAT). Prescribing physicians should be aware of a number of aspects of OPAT which distinguish it from other forms of therapy. These include the required teamwork, communication, monitoring, and outcome measurements (tables 3 and 4). Key elements required for an outpatient parenteral antimicrobial therapy (OPAT) program. Key elements required for evaluating an outpatient parenteral antimicrobial therapy (OPAT) program when the patient is to be referred. The physician has a unique role on the OPAT team, which may also include nursing, pharmacy, and social services. These responsibilities include establishing a diagnosis, prescribing treatment, determining the appropriate site of care, monitoring during therapy, and assuring the overall quality of care. Antimicrobial selection for OPAT is different from that for therapy in the hospital. Once-daily drug administration has many advantages. Potential for adverse effects and the stability of an antimicrobial once it is mixed must be considered (tables 5–7). Properties of commonly prescribed antimicrobials at various temperatures. Suggestions for laboratory parameters that should be monitored weekly during outpatient parenteral antimicrobial therapy (OPAT). The importance of administering the first dose of an antibiotic in a supervised setting is emphasized. Regular clinical and laboratory monitoring of patients receiving OPAT is essential and varies with the antimicrobial chosen (table 8). Outcome measures for outpatient parenteral antimicrobial therapy (OPAT). Outcomes measures should be an integral part of any OPAT program, to assure the effectiveness and quality of care (table 9). Internet resources with information on outpatient parenteral antimicrobial therapy (OPAT). Children receiving OPAT must be considered differently because of their special needs. The practice of administering intravenous antimicrobial therapy in the home and in alternate care settings has grown rapidly since it was first described in 1974 by Rucker and Harrison [1]. The most common infections treated and antimicrobials used by a variety of programs are shown in table 1. In the United States, OPAT is estimated to be a multibillion-dollar-a-year industry and is provided to 1 in 1000 Americans each year [10]. The growth of OPAT has been fueled by a variety of factors including the push for cost containment, the development of antimicrobial agents that can be administered once daily, technological advances in vascular access and infusion devices, increased acceptance of such therapy by both patients and health care personnel, and the availability of reliable and skilled services for OPAT in the community. Although OPAT has become widely accepted as a form of medical therapy (see Appendix), more information is needed regarding its benefits, safety, and limitations. This is especially true with the economic incentives for early discharge that exist for payors. These guidelines update those written in 1997 [11] and are intended to ensure successful implementation of parenteral antimicrobial services for patients in varied community settings, including the home and outpatient facilities, such as physicians' offices, hospital clinics, ambulatory-care centers, day hospitals, and skilled nursing facilities. They have been formulated to incorporate the perspectives of the team of physicians, nurses, pharmacists and other health care professionals necessary for an effective and safe program [6, 8, 12]. Advice and participation were requested of the leading infusion-nurse, pharmacy, and to a on the The were formulated from the collective clinical experience of the of and from the organizations. In the of the and quality of in of OPAT is by a of prospective studies and a number of are The information can a for programs to
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Outpatient parenteral antibiotic therapy (OPAT) is efficacious, safe, and cost-effective for a variety of infections, [323][324][325] including IE that requires prolonged parenteral therapy in hospitalized patients who otherwise no longer require inpatient care but do require continued parenteral antimicrobial therapy.”
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Kaushal, R. (2001) · JAMA · doi:10.1001/jama.285.16.2114 · Cited by 1,917
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Guidelines for the prevention of intravascular catheter-related infections
da Silva, G. D., de Almeida, V. S., Querido, D. L., Esteves, A. P. V. D. S., dos Santos, J. P. O., & Rezende, T. F. (2012) · doi:10.5205/3705 · Cited by 1,119
Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A., Marrie, T. J., Sarosi, G. A., Torres, A., & Yu, V. L. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1418 · Cited by 1,045
(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
Quality of Care, Process, and Outcomes in Elderly Patients With Pneumonia
Meehan, T. P. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550230056037 · Cited by 919
Research works printed but not linked: 28
- Winters, 1992, Home infusion therapy: a service and demographic profile: a report for the National Alliance for Infusion Therapy, 1
- Hankwitz, 1994, The expanding and increasingly important role of the home health care agency medical director, Am Ac Home Care Phys Newsletter, 6, 8
- Tice, 1993, Growing pains in outpatient intravenous antibiotic therapy, Infect Dis Clin Pract, 1, 74
- 1986, Wickline v State of California, 228 Cal. Rptr. 661, 192. Cap. App. 3d 1630
- 1981, Physicians, surgeons and other healers. American Jurisprudence, 226
- Tice, 1997, Delivery models for outpatient parenteral antimicrobial therapy. In: Outpatient parenteral antimicrobial therapy: current status, 7
- Residency Review Committee, Specific program content. CAAR Program Information from Workshop for Internal Medicine Subspecialty Residencies in Infectious Disease. 11. 2001. American Board of Internal Medicine. Ref Type: Conference Proceeding.
- Lonsway, 2001, Intravenous therapy in the home, 501
- Mortlock, 2001, Intravenous therapy in the alternative care setting, 535
- Skokal, 2000, IV push at home?, RN, 63, 26
- Tice, 2002, Adverse effects with intravenous antibiotics with OPAT
- Rehm, 2000, Rates of adverse events associated with community-based parenteral anti-infective therapy, J Clin Outcomes Manage, 7, 23
- Martinelli, 1988, Aminoglycoside questionnaire results
- Hautekeete, 1995, Hepatotoxicity of antibitoics, Acta Gastroenterol Belg, 58, 290
- 1999, 2000–2001 Comprehensive accreditation manual for ambulatory care
- Barrell, 1998, ORYX: outcomes measurement and accreditation, Infusion, May, 37
- Poole, 1998, Outcomes measurements: making sense of the data, Infusion, May, 25
- Tice, 2000, Documenting the value of OPAT: outcomes studies and patient registries, Can J Infect Dis, 10, 45
- Tice, 2000, Outcomes registry for outpatient IV antimicrobial therapy, Infusion, May, 27
- Outpatient Parenteral Antimicrobial Therpay Outcomes Registry Web site
- Tice, 2003, Reasons for failures with OPAT [abstract 293]
- Arditi, 1990, Convalescent outpatient therapy for selected children with acute bacterial meningitis, Semin Pediatr Infect Dis, 1, 404
- Sudela, 1990, Nursing aspects of pediatric home infusion therapy for the treatment of serious, Semin Pediatr Infect Dis, 1, 306
- Tice, 2003, OPAT outcomes registry evaluaton of diabetic extremity infections [abstract 291]
- Wai, 1999, A cost analysis of an outpatient parenteral antibiotic program (OPAT): a Canadian teaching hospital and ministry of health perspective, 133
- Tice, 1997, Osteomyelitis
- Rehm, 1992, Home intravenous antibiotic therapy (HIVAT) for endocarditis
- Gentry, 1989, New approches to the diagnosis and treatment of infective endocarditis, Texas Heart Institute J, 16, 250
Cited by
Items 101–200 of 575
Blumenthal, K. G., Youngster, I., Rabideau, D. J., Parker, R. A., Manning, K. S., Walensky, R. P., & Nelson, S. B. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.005 · Cited by 55
Voumard, R. R., Neyghem, N. V., Cochet, C., Gardiol, C., Decosterd, L. A., Buclin, T., & Vallière, S. D. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw582 · Cited by 55
D’Couto, H. T., Robbins, G. K., Ard, K. L., Wakeman, S. E., Alves, J., & Nelson, S. B. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy056 · Cited by 55
Huang, V., Ruhe, J., Lerner, P., & Fedorenko, M. (2018) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0240-3 · Cited by 55
Sharma, R. K., Loomis, W., & Brown, R. B. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200508000-00002 · Cited by 55
Dardis, C., Milton, K., Ashby, L. S., & Shapiro, W. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00220 · Cited by 55
Partridge, D. G., O'Brien, E., & Chapman, A. L. N. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-130355 · Cited by 54
Keller, S. C., Ciuffetelli, D., Bilker, W. B., Norris, A. H., Timko, D. R., Rosen, A., Myers, J. S., Hines, J. M., & Metlay, J. P. (2013) · Journal of Pharmacy Technology · doi:10.1177/8755122513500922 · Cited by 55
An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort
Seetoh, T., Lye, D. C., Cook, A. R., Archuleta, S., Chan, M., Sulaiman, Z., Zhong, L., Llorin, R. M., Balm, M. N. D., & Fisher, D. A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.01.015 · Cited by 54
Tan, C., Shojaei, E., Wiener, J., Shah, M., Koivu, S. L., & Silverman, M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.12974 · Cited by 54
Conant, M. M., Erdman, S. M., & Osterholzer, D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku015 · Cited by 54
Hitchcock, J., Jepson, A., Main, J., & Wickens, H. J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp212 · Cited by 54
Mirón-Rubio, M., Ramallo, V. J. G., Estrada, O., Sanroma, P., Segado-Soriano, A., Mujal, A., Vizoso, M. D. R., García-Lezcano, M., Martín-Blanco, N., Florit, L., et al. (2016) · Future Microbiology · doi:10.2217/fmb.15.141 · Cited by 53
Hot topics in the diagnosis and management of skin and soft-tissue infections
Esposito, S., Bassetti, M., Bonnet, É., Bouza, E., Chan, M., Simone, G. D., Dryden, M., Gould, I. M., Lye, D. C., Saeed, K. B. A., et al. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.011 · Cited by 53
Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review
Psaltikidis, E. M., da Silva, E. N., Bustorff‐Silva, J. M., Moretti, M. L., & Resende, M. R. (2017) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1360767 · Cited by 52
Management of Aminoglycosides in the Intensive Care Unit
Radigan, E., Gilchrist, N. A., & Miller, M. A. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610377968 · Cited by 52
Endocardite Infecciosa: Ainda mais Desafios que Certezas
Sousa, C., & Pinto, F. J. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200798 · Cited by 52
Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?
Steffens, E., Quintens, C., Derdelinckx, I., Peetermans, W. E., Eldere, J. V., Spriet, I., & Schuermans, A. (2018) · Infection · doi:10.1007/s15010-018-1250-1 · Cited by 51
Hagihara, M., Crandon, J. L., & Nicolau, D. P. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.632631 · Cited by 51
Telemedicine: The Future of Outpatient Therapy?
Eron, L. J. (2010) · Clinical Infectious Diseases · doi:10.1086/653524 · Cited by 51
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review
Wolie, Z. T., Roberts, J. A., Gilchrist, M. J., McCarthy, K. L., & Sime, F. B. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae177 · Cited by 50
Infective Endocarditis in Low- and Middle-Income Countries
Njuguna, B., Gardner, A. F., Karwa, R., & Delahaye, F. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2016.08.011 · Cited by 50
Berrevoets, M. A. H., Oerlemans, A. J. M., Tromp, M., Kullberg, B. J., ten Oever, J., Schouten, J. A., & Hulscher, M. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-024564 · Cited by 50
Nathwani, D., Dryden, M., & Garau, J. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.023 · Cited by 48
Shah, A., Petrak, R. M., Fliegelman, R. M., Shrestha, N. K. M., Allison, G. M., Zurlo, J. J., Parker, S., Poretz, D. M., McKinsey, D. S., Dougherty, M. J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy674 · Cited by 48
Self-citationDiamantis, S., Dawudi, Y., Cassard, B., Longuet, P., Lesprit, P., & Gauzit, R. (2020) · Infectious Diseases Now · doi:10.1016/j.medmal.2020.10.019 · Cited by 48
Mansour, O., Heslin, J., & Townsend, J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky294 · Cited by 47
Antimicrobial Stewardship Interventions
Hamilton, K. W., & Fishman, N. O. (2014) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.01.003 · Cited by 46
Measures Used to Assess the Impact of Interventions to Reduce Low-Value Care: a Systematic Review
Maratt, J. K., Kerr, E. A., Klamerus, M. L., Lohman, S. E., Froehlich, W., Bhatia, R. S., & Saini, S. D. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05069-5 · Cited by 46
Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
Mahoney, M. V. G., Childs‐Kean, L. M., Khan, P. F., Rivera, C. G., Stevens, R. W., & Ryan, K. L. (2021) · Current Infectious Disease Reports · doi:10.1007/s11908-021-00766-x · Cited by 46
Pneumonia in Hospitalized Children
Sandora, T. J., & Harper, M. B. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.03.004 · Cited by 46
Shrestha, N. K. M., Mason, P., Gordon, S., Neuner, E. A., Nutter, B., O’Rourke, C., & Rehm, S. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt512 · Cited by 46
Self-citationSequential intravenous-to-oral outpatient antibiotic therapy for MRSA bacteraemia: one step closer
Jorgensen, S. C. J., Lagnf, A. M., Bhatia, S., Shamim, M.-D., & Rybak, M. J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky452 · Cited by 45
Outpatient parenteral antimicrobial therapy for infective endocarditis: A cost-effective strategy
Lacroix, A., Revest, M., Patrat-Delon, S., Lemaitre, F., Donal, E., Lorleac’h, A., Arvieux, C., Michelet, C., & Tattevin, P. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2014.05.001 · Cited by 45
Petrak, R. M., Skorodin, N. C., Fliegelman, R. M., Hines, D. W., Chundi, V. V., & Harting, B. P. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw193 · Cited by 44
Saini, E., Ali, M., Du, P., Crook, T., & Zurlo, J. J. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz073 · Cited by 44
Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy
Krah, N. M., Bardsley, T. R., Nelson, R. E., Esquibel, L., Crosby, M., Byington, C. L., Pavia, A. T., & Hersh, A. L. (2019) · Hospital Pediatrics · doi:10.1542/hpeds.2018-0193 · Cited by 44
Perspectives of Patients on Outpatient Parenteral Antimicrobial Therapy: Experiences and Adherence
Hamad, Y., Dodda, S., Frank, A., Beggs, J., Sleckman, C., Kleinschmidt, G., Lane, M., & Burnett, Y. J. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa205 · Cited by 44
Shrestha, N. K. M., Bhaskaran, A., Scalera, N. M., Schmitt, S. K., Rehm, S. J., & Gordon, S. M. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.1902 · Cited by 44
Self-citationHabib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73131-8 · Cited by 43
Berrevoets, M. A. H., ten Oever, J., Oerlemans, A. J. M., Kullberg, B. J., Hulscher, M., & Schouten, J. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz362 · Cited by 42
Outcomes and Pharmacoeconomic Analysis of a Home Intravenous Antibiotic Infusion Program in Veterans
Ruh, C. A., Parameswaran, G. I., Wojciechowski, A. L., & Mergenhagen, K. A. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.09.009 · Cited by 42
Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people
Mujal, A., Sola, J., Hernandez, M., Villarino, M.-A., Baylina, M., Taján, J., & Oristrell, J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv478 · Cited by 41
Neutropenia Associated with Long-Term Ceftaroline Use
LaVie, K. W., Anderson, S. W., O’Neal, H. R., Rice, T. W., Saavedra, T. C., & O’Neal, C. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01471-15 · Cited by 41
Impact of Antimicrobial Stewardship for Pediatric Outpatient Parenteral Antibiotic Therapy
Hersh, A. L., Olson, J. A., Stockmann, C. R., Thorell, E. A., Knackstedt, E. D., Esquibel, L., Sanderson, S. K., & Pavia, A. T. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix038 · Cited by 41
McCarthy, M. W., Keyloun, K. R., Gillard, P. J., Choi, J. J., Pickell, N., Copp, R., & Walsh, T. J. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-00275-4 · Cited by 40
Fanucchi, L. C., Leedy, N., Li, J., & Thornton, A. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2582 · Cited by 40
Fanucchi, L. C., WALSH, S. L., Thornton, A., & Lofwall, M. R. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105760 · Cited by 39
Epidemiology of Primary Ophthalmic Inpatient Admissions in the United States
Iftikhar, M., Junaid, N., Lemus, M., Mallick, Z., Mina, S. A., Hannan, U., Canner, J. K., Latif, A., & Shah, S. M. (2017) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2017.10.014 · Cited by 39
Larioza, J., Heung, L. J., Girard, A. W., & Brown, R. B. (2009) · Southern Medical Journal · doi:10.1097/smj.0b013e3181a4eef2 · Cited by 38
Antimicrobial Stewardship at Transition of Care from Hospital to Community
Shrestha, N. K. M., Bhaskaran, A., Scalera, N. M., Schmitt, S. K., Rehm, S. J., & Gordon, S. M. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/664758 · Cited by 38
Self-citationGramlich, Y., Johnson, T., Kemmerer, M., Walter, G., Hoffmann, R. F. G., & Klug, A. (2019) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-019-05627-8 · Cited by 38
Prosthetic valve endocarditis: state of the heart
Nagpal, A., Sohail, M. R., & Steckelberg, J. M. (2012) · Clinical Investigation · doi:10.4155/cli.12.70 · Cited by 31
Successful outpatient parenteral antibiotic therapy delivery via telemedicine
Tan, S. J., Ingram, P. R., Rothnie, A. J., Whitmore, T., Robinson, J. O., Hatch, J. B., Italiano, C. M., & Heath, C. H. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx203 · Cited by 38
Mohammed, S. A., Roberts, J. A., Cotta, M. O., Rogers, B. A., Pollard, J., Assefa, G. M., Erku, D., & Sime, F. B. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107263 · Cited by 37
Goodlet, K. J., & Fairman, K. A. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy329 · Cited by 37
The safety of treatment options for acute bacterial skin and skin structure infections
Bassetti, M., Peghin, M., Castaldo, N., & Giacobbe, D. R. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1621288 · Cited by 37
Pérez‐López, J., Laporte, A. S. J., Pardos‐Gea, J., Melenchón, E. T., Ortin, E. L., Guirado, A. B., & Vilardell, M. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01747.x · Cited by 37
Pajarón, M., Fernández-Miera, M. F., Allende, I., Arnáiz, A., Gutiérrez‐Cuadra, M., Cobo-Belaustegui, M., Armiñanzas, C., de Berrazueta, J. R., Fariñas, M. C., & Sanroma, P. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.01.001 · Cited by 37
Sauberan, J. B., & Bradley, J. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00292-9 · Cited by 38
Self-citationJacqueline, C., Caillon, J., Grossi, O., Le Mabecque, V., Miegeville, A.-F., Bugnon, D., Batard, E., & Potel, G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01501-05 · Cited by 36
Reidy, P., Breslin, T., & Muldoon, E. G. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae111 · Cited by 36
Hale, C. M., Steele, J. M., Seabury, R. W., & Miller, C. D. (2017) · Journal of Pharmacy Practice · doi:10.1177/0897190016688771 · Cited by 36
Complications Associated With Outpatient Parenteral Antibiotic Therapy in Children
Lê, J., Agustin, M. S., Hernandez, E. A., Tran, T. T. L., & Adler‐Shohet, F. C. (2010) · Clinical Pediatrics · doi:10.1177/0009922810374210 · Cited by 36
Oritavancin: A New Opportunity for Outpatient Therapy of Serious Infections
Tice, A. D. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1047 · Cited by 35
Self-citationDababneh, A. S., & Sohail, M. R. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10169 · Cited by 35
Yan, M., Elligsen, M., Simor, A. E., & Daneman, N. (2016) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2016/8435257 · Cited by 35
Karumathil, D. P., Yin, H., Johny, A. K., & Venkitanarayanan, K. (2016) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-15-548 · Cited by 35
Kaul, C. M., Haller, M. D., Yang, J., Solomon, S., Wang, Y., Wu, R., Yu, M., Pitts, R. A., & Phillips, M. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.313 · Cited by 34
Agnihotri, G., Gross, A. E., Seok, M., Yen, C. Y., Khan, F., Ebbitt, L. M., Gay, C., Bleasdale, S. C., Sikka, M. K., & Trotter, A. B. (2023) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.330 · Cited by 34
Htin, A. K. F., Friedman, N. D., Hughes, A. J., O'Brien, D. P., Huffam, S., Redden, A. ‐., & Athan, E. (2013) · Internal Medicine Journal · doi:10.1111/imj.12081 · Cited by 34
Adverse Events in Pediatric Patients Receiving Long-Term Outpatient Antimicrobials
Olson, S. C., Smith, S. D., Weissman, S. J., & Kronman, M. P. (2014) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piu037 · Cited by 34
Beieler, A. M., Magaret, A., Zhou, Y., Schleyer, A. M., Wald, A., & Dhanireddy, S. (2019) · Journal of Hospital Medicine · doi:10.12788/jhm.3138 · Cited by 34
Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy
Palms, D. L., & Jacob, J. T. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz150 · Cited by 34
Experience with Community‐Based Amphotericin B Infusion Therapy
Malani, P., DePestel, D. D., Riddell, J., Bickley, S. K., Klein, L. R., & Kauffman, C. A. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.5.690.63591 · Cited by 34
Loesch, G. H., Cruz, J. A. W., Gasparetto, J., Oliveira, D. D. S., Telles, J. P., & Tuon, F. F. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.22 · Cited by 33
Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting
García-Queiruga, M., Cortizas, B. F., Alfonsín, F. L., Pértega-Díaz, S., & Martín‐Herranz, I. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/122.2020 · Cited by 33
Lodise, T. P., Fan, W., & Sulham, K. A. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1076325 · Cited by 33
Patel, D. A., Stephens, J. M. L., Gao, X., Verheggen, Shelbaya, A., & Haider, S. (2013) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s46991 · Cited by 33
Chung, E. K., Beeler, C., Muloma, E., Osterholzer, D., Damer, K. M., & Erdman, S. M. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150201 · Cited by 33
Nathwani, D. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp245 · Cited by 33
Extended stability of antimicrobial agents in administration devices
Jenkins, A., Hills, T., Santillo, M., Gilchrist, M. J., & on behalf of the Drug Stability Working Group of the BSAC UK OPAT Initiative (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw556 · Cited by 32
Schmidt, M., Hearn, B., Gabriel, M., Spencer, M., & McCurdy, L. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx086 · Cited by 32
Faden, D., & Faden, H. S. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318193ef38 · Cited by 32
Carr, D. R., Stiefel, U., Bonomo, R. A., Burant, C. J., & Sims, S. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy089 · Cited by 31
Ray, V., Waite, M. R., Spexarth, F. C., Korman, S. T., Berget, S., Kodali, S., Kress, D. C., Guenther, N., & Murthy, V. S. (2020) · Psychosomatics · doi:10.1016/j.psym.2020.06.019 · Cited by 31
Shah, P. J., Bergman, S., Graham, D. R., & Glenn, S. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014544786 · Cited by 31
Self-citationAdverse Events in Pediatric Patients Receiving Long-term Oral and Intravenous Antibiotics
Murphy, J. L., Fenn, N. E., Pyle, L. L., Heizer, H. R., Hughes, S., Nomura, Y., Child, J., & Parker, S. K. (2016) · Hospital Pediatrics · doi:10.1542/hpeds.2015-0069 · Cited by 31
Seval, N., Eaton, E., & Springer, S. A. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz539 · Cited by 31
Mace, A. O., McLeod, C., Yeoh, D. K., Vine, J., Chen, Y., Martin, A. C., Blyth, C. C., & Bowen, A. C. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2017-313071 · Cited by 31
Outpatient Parenteral Antimicrobial Therapy in Pediatric Medicaid Enrollees
Goldman, J. L., Richardson, T., Newland, J. G., Lee, B. R., Gerber, J. S., Hall, M., Kronman, M. P., & Hersh, A. L. (2016) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv106 · Cited by 30
Safety of Outpatient Parenteral Antimicrobial Therapy in Children
Fernandes, P., Milliren, C. E., Mahoney-West, H., Schwartz, L., Lachenauer, C. S., & Nakamura, M. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001716 · Cited by 29
Managing an outpatient parenteral antibiotic therapy team: challenges and solutions
Nguyen, H., Halilovic, J., & Christensen, C. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s48906 · Cited by 29
Gardiol, C., Voumard, R. R., Cochet, C., & Vallière, S. D. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2606-z · Cited by 29
Stability of benzylpenicillin potassium and ampicillin in an elastomeric infusion pump
Nakamura, T., Enoki, Y., Uno, S., Uwamino, Y., Iketani, O., Hasegawa, N., & Matsumoto, K. (2018) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.04.003 · Cited by 29
Tonna, A. P., Anthony, G., Tonna, I., Paudyal, V., Forbes‐McKay, K., Laing, R. B. S., Mackenzie, A. R., Falconer, S., McCartney, G., & Stewart, D. C. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027475 · Cited by 29
Schrank, G. M., Wright, S. B., Branch‐Elliman, W., & LaSalvia, M. T. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.107 · Cited by 29
Suleyman, G., Kenney, R., Zervos, M. J., & Weinmann, A. (2016) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12465 · Cited by 28
Clinical and economic implications of urinary tract infections
Steiger, S. N., Comito, R. R., & Nicolau, D. P. (2017) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1358618 · Cited by 28
López, J. P., San‐José, A., Alemán, C., Pardos‐Gea, J., & Tarrés, M. V. (2008) · Medicina Clínica · doi:10.1016/s0025-7753(08)72260-7 · Cited by 28
Metadata
- Authors
- Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N.
- Affiliations
- University of Hawaiʻi at Mānoa (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Rady Children's Hospital-San Diego (US)
- Consultants in Infectious Diseases, Lubbock, Texas
- Springfield Clinic (US)
- Morgantown Internal Medicine Group, Morgantown, West Virginia
- Pfizer (United States) (US)
- Florida Infection Physicians, Gainsville
- Hennepin County Medical Center (US)
- Corresponding author
- Tice, Alan D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-15
- Volume
- 38
- Issue
- 12
- Pages
- 1651-1671
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141994303
- Cited by
- 532
- References
- 239
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 18 · 2023: 17 · 2022: 21 · 2021: 21 · 2020: 31 · 2019: 38 · 2018: 48 · 2017: 40 · 2016: 43 · 2015: 32 · 2014: 36 · 2013: 31 · 2012: 21
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- outpatient parenteral antimicrobial therapy, outpatient antibiotic therapy, patient selection, antimicrobial selection, once-daily dosing, drug stability, laboratory monitoring, adverse drug reactions, quality of care, multidisciplinary team
- MeSH terms
- Adult, Anti-Bacterial Agents, Child, Home Care Services, Humans, Infusions, Intravenous, Outpatients, Patient Care Team, Pediatrics, Drug Monitoring, Outcome Assessment, Health Care, Patient Selection, Home Infusion Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.